DAPT (GSI-IX) CAS 208255-80-5 γ-Secretase Inhibitor Inhibitor> 98.0% (HPLC) Factory
Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica DAPT (GSI-IX) (CAS: 208255-80-5) magna qualitate γ-Secretase Inhibitoris.Ruifu chemical seriem amino acidarum et derivatorum supplet.Praebere possumus terrarum traditionem, parvas et parvas quantitates in promptu.Purchase DAPT,Please contact: alvin@ruifuchem.com
| Nomen chemicum | DAP |
| Synonyma | GSI-IX;γ-Secretase Inhibitor IX;gamma-Secretase Inhibitor;LY-374973;(3,5-Difluorophenylacetyl)-Ala-Phg-OtBu;(3,5-Difluorophenylacetyl)-L-Alanyl-L-2-Phenylglycine tert-Butyl Ester;N-[N.(2S)-N. |
| Stock Status | In Stock |
| CAS Number | 208255-80-5 |
| Formulae hypotheticae | C23H26F2N2O4 |
| M. Pondus | 432.47 |
| Density | 1.213 g/cm3 |
| Liquescens punctum | 142.0~146.0℃ |
| Sensitiva | Calor Sensitiva |
| Solubilitas | Solutum in DMSO |
| Repono Nativ. | Condite in 2-8℃ |
| COA & MSDS | Praesto |
| Brand | Ruifu Chemical |
| Salus Denunciationes | 24/25 - contactus cum cute et oculis fuge. | ||
| WGK Germania | 3 | HS Code* | 2922491990 |
| Items | Signa inspectionis | Proventus |
| Aspectus | Alba vel Off-White Crystalline pulveris | Conforms |
| Damnum in Siccatio | <0.40% | 0.21% |
| Residere in Ignition | <0.40% | 0.20% |
| Metalla gravia (ut Pb) | ≤20ppm | <20ppm |
| Asssay / Analysis Methodo | >98.0% (HPLC) | 98.62% |
| Carbon by Elemental Analysis | 62.1~64.1% | Conforms |
| Nitrogen by Elemental Analysis | 6.20~6.70% | Conforms |
| Infrared Imaginis | Conformat ut Structure | Conforms |
| NMR Imaginum | Conformat ut Structure | Conforms |
| conclusio | This Product by Inspection Accords with the Enterprise Standard | |
| Fasciae vita | XXIV Menses ex Manufacture Date si Repono Proprie | |
sarcina: Fluorinated Utrem, aluminium ffoyle, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Condite in vasis obsignatis ad frigus, siccum (ad 2-8℃ thesaurum) et ab incompossibilibus substantiis horreis ventilatis.A luce et humore protege.
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Annorum Usus?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
DAPT (GSI-IX) (CAS: 208255-80-5), potens et specifica inhibitor γ-secretasis.DAPT inhibitor γ-secretasis (IC50 in primis neuronibus humanis = 115 nM pro totali Aβ vel 200 nM pro Aβ42 in specie).Oralis administratio DAPT ostensa est reducere gradus Aβ in extractum cerebri, fluidum cerebrospinum et plasma a muribus et muribus.DAPT stipitibus SCARIFICATIO significans quae neuronalem differentiam cellularum praecursoris promovet.Auget iPS cellulas sine oncogenes KLF4 et CMYC5.Cellula commeabile.DAPT in studio formationis β-amyloideae adhibetur.DAPT monstratum est notch inhibere significationis in studiis morborum autoimmunerum et lymphoproliferativorum, sicut ALPIS et lupus erythematosus, necnon in incremento cellae cancri, angiogenesis et differentiatione plurium cellularum caulis humanorum inductorum.nia SCARIFICATIO significans in vitro.Inhibet productionem totalis Aβ et Aβ42 in primis humanis culturae (valores IC50 115 et 200 nM, respective) nullo effectu in gradibus APPα et APPβ.Sanguinis obice permeabile cerebrum.3D Incrementum matricis componentis et componentis differentiationis instrumentorum organoidis cerebri.
